• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.

作者信息

Hattori K, Hasumura Y, Takeuchi J

出版信息

Gastroenterol Jpn. 1984 Feb;19(1):59-64. doi: 10.1007/BF02774647.

DOI:10.1007/BF02774647
PMID:6373477
Abstract

Since glucagon and insulin (G/I) have been suggested to be hepatotrophic substances, the effect of G/I infusion on the ability to excrete water and sodium was tested in seven patients with cirrhosis and ascites (decompensated group), and compared with that in seven cirrhotics without ascites (compensated group). A constant infusion of 1 U glucagon and 10 U regular insulin over 2 hours daily for 14 days resulted in a significant improvement of prothrombin time in the decompensated group. Concomitantly, an increase in urine volume (62%, p less than 0.02) and a tendency toward an increase in urinary sodium excretion (68%, 0.05 less than p less than 0.1) were observed only in the decompensated group after the G/I infusion. In addition, these were associated with increases in creatinine clearance and osmotic clearance. These results suggest that glucagon and insulin merit further study in hepatorenal syndrome cases.

摘要

相似文献

1
Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.
Gastroenterol Jpn. 1984 Feb;19(1):59-64. doi: 10.1007/BF02774647.
2
Effects of insulin and glucagon on serum amino acid concentrations in liver disease.胰岛素和胰高血糖素对肝脏疾病患者血清氨基酸浓度的影响。
Acta Med Okayama. 1982 Dec;36(6):441-6. doi: 10.18926/AMO/30669.
3
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
4
Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject.胰高血糖素对空腹肥胖受试者利钠作用及葡萄糖诱导的钠潴留的影响。
Eur J Clin Invest. 1977 Jun;7(3):167-75. doi: 10.1111/j.1365-2362.1977.tb01593.x.
5
[Preoperative glucagon-insulin therapy on the patient with hepatic failure secondary to combined valvular disease].
Kyobu Geka. 1984 Aug;37(9 Suppl):732-5.
6
Effects of somatostatin on renal function in cirrhosis.
Gastroenterology. 1992 Dec;103(6):1868-74. doi: 10.1016/0016-5085(92)91446-b.
7
Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.口服米索前列醇或静脉注射前列腺素E2并不能改善肝硬化腹水合并低钠血症或肾衰竭患者的肾功能。
J Hepatol. 1993 Feb;17(2):220-6. doi: 10.1016/s0168-8278(05)80042-x.
8
Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.长期服用单硝酸异山梨酯不会损害肝硬化患者的肾功能。
Hepatology. 1996 May;23(5):1135-40. doi: 10.1053/jhep.1996.v23.pm0008621145.
9
Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.肝硬化的并发症。II. 肾脏与循环功能障碍。一个重要临床问题中的光明与阴影
J Hepatol. 2000;32(1 Suppl):157-70. doi: 10.1016/s0168-8278(00)80423-7.
10
Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.血管加压素V1a/V2受体拮抗剂考尼伐坦对肝硬化腹水大鼠肾脏水代谢及全身血流动力学的影响。
J Hepatol. 2003 Jun;38(6):755-61. doi: 10.1016/s0168-8278(03)00116-8.

本文引用的文献

1
Thrombotest. A new method for controlling anticoagulant therapy.凝血试验。一种控制抗凝治疗的新方法。
Lancet. 1959 Nov 7;2(7106):754-8. doi: 10.1016/s0140-6736(59)90857-8.
2
SPONTANEOUS RECOVERY FROM THE HEPATORENAL SYNDROME: REPORT OF FOUR CASES.肝肾综合征的自发恢复:4例报告
N Engl J Med. 1965 Apr 29;272:895-7. doi: 10.1056/NEJM196504292721706.
3
THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.肝硬化中的肾脏。II. 肾功能紊乱。
Ann Intern Med. 1964 Mar;60:366-77. doi: 10.7326/0003-4819-60-3-366.
4
"Cirrhotic glomerulosclerosis," a renal lesion associated with hepatic cirrhosis.“肝硬化性肾小球硬化症”,一种与肝硬化相关的肾脏病变。
Lab Invest. 1959 Sep-Oct;8:962-78.
5
The role of the kidney in Laennec's cirrhosis of the liver.肾脏在Laennec肝硬化中的作用。
Medicine (Baltimore). 1958 Dec;37(4):299-316. doi: 10.1097/00005792-195812000-00002.
6
Electrolyte and circulatory changes in terminal liver failure.终末期肝功能衰竭时的电解质及循环系统变化
Lancet. 1956 Dec 1;271(6953):1121-5. doi: 10.1016/s0140-6736(56)90149-0.
7
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.肝肾综合征患者尸体肾移植。晚期肝病肾衰竭功能性本质的证据。
N Engl J Med. 1969 Jun 19;280(25):1367-71. doi: 10.1056/NEJM196906192802501.
8
Recovery from "hepatorenal syndrome" after orthotopic liver transplantation.原位肝移植后“肝肾综合征”的恢复
N Engl J Med. 1973 Nov 29;289(22):1155-9. doi: 10.1056/NEJM197311292892201.
9
Estimation of the functional reserve of human liver.人体肝脏功能储备的评估。
Ann Surg. 1974 Oct;180(4):592-8. doi: 10.1097/00000658-197410000-00024.
10
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.门静脉血中促肝细胞物质的起源、激素性质及作用。
Surg Gynecol Obstet. 1973 Aug;137(2):179-99.